65,437 trials
Papilloma Viral Infection
Primary: Geometric Mean Titers (GMTs) to HPV Types 6/11/16/18 — 758.3; 618.4; 681.7; 769.1 milli Merck U/mL — p=<0.001
Prostate Cancer Adenocarcinoma in Situ
Primary: Intraprostatic CD8+ T Cell Infiltration — 204.81; 263.33 log10 (cells/mm^2)
Fabry Disease
Primary: Change In Area Under The Plasma Concentration Versus Time Curve (AUC) For Active α-Galactosidase A (α-Gal A) Levels After Administration Of Migalastat — 1132.72…
Stress Disorder - Post-traumatic (Acute)
Primary: Severity of PTSD Symptoms — 43.4; 43.9 CAPS total Score at treatment end — p=0.927
Diabetes Mellitus, Type 2
Primary: Pharmacodynamics (PD): Average Glucose Infusion Rate From Euglycemic 2-step Hyperinsulinemic Clamp (M-value) — 59.09; 55.52; 17.22; 19.67 milligram*hour per deciliter
Smoking · Smoking Cessation
Primary: Smoking Status Using a Point of Care Test for Measuring Carbon Monoxide (CO) — 22.0; 23.0 parts per million
Hearing Loss
Primary: Scalar Position of Electrode Array Determined With Computer Tomography (CT) Scan — 44; 0 Participants
Marijuana Use Disorder
Primary: Change From Baseline in Iowa Gambling Task Scores [Objective Measure of Decision Making] — 3.7; 10.1; 4.4 mean number of cards
Type 2 Diabetes Mellitus
Primary: Adjusted Mean Change From Baseline in Hemoglobin A1c (HbA1c) at Week 24 — -0.37; -0.03 percent — p=<0.001
Advanced Solid Tumors · Lymphoma
Primary: Cmax: Maximum Observed Plasma Concentration for Alisertib and Drug-Related Material Following a Single Dose of [^14C]-Alisertib Oral Solution — 2183.3; 2606.7 nanomole…
Non-infectious Intermediate Uveitis · Non-infectious Posterior Uveitis · Non-infectious Panuveitis
Primary: Number of Participants With Response Rate for the Individual Response Criteria - in the Study Eye — 3; 3; 0; 1 Participants
Arthritis, Rheumatoid; Arthritis, Psoriatic
Primary: Injection Site Pain — 23.6; 19.8 mm — p=0.048
Sedation
Primary: Decreased Minute Ventilation — 0.736; 0.764 percentage of baseline — p=<0.0001
Smoking
Primary: Change in Cigarette Consumption — -1.6; -0.05 cigarettes per day — p=<0.001
Hemoglobinuria, Paroxysmal
Primary: Peak And Trough Concentrations Of Eculizumab In Serum At Week 12 — 192.5; 425.4 μg/mL